| __timestamp | ACADIA Pharmaceuticals Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 101881000 |
| Thursday, January 1, 2015 | 76369000 | 4011000 |
| Friday, January 1, 2016 | 4406000 | 102026000 |
| Sunday, January 1, 2017 | 13060000 | 96171000 |
| Monday, January 1, 2018 | 18330000 | 66449000 |
| Tuesday, January 1, 2019 | 19598000 | 42672000 |
| Wednesday, January 1, 2020 | 20550000 | 42534000 |
| Friday, January 1, 2021 | 19141000 | 3068000 |
| Saturday, January 1, 2022 | 10166000 | 1400000 |
| Sunday, January 1, 2023 | 45731000 | 3008000 |
Data in motion
In the dynamic world of biotechnology, understanding financial health is crucial. This analysis delves into the cost of revenue trends for ACADIA Pharmaceuticals Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, ACADIA Pharmaceuticals saw a significant fluctuation, with costs peaking in 2015 and 2023, while Celldex Therapeutics experienced a dramatic decline, with costs dropping by over 97% from 2014 to 2023. This stark contrast highlights the volatile nature of the biotech industry, where strategic decisions and market conditions can lead to rapid financial shifts. The data reveals that while ACADIA's cost of revenue decreased by approximately 25% from its 2015 peak, Celldex's costs plummeted, reflecting potential operational efficiencies or strategic pivots. Such insights are invaluable for investors and stakeholders aiming to navigate the complexities of the biotech sector.
Cost of Revenue Trends: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Veracyte, Inc. vs Celldex Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Celldex Therapeutics, Inc.